Balegem
Belgium
81
2026-05-07
The entities that hold a legal rights for patent applications filed by inventor Tavernier Jan:
Jan Tavernier from Balegem, BE has applied for patents for these inventions. The list has both pending applications and granted patents:
CD8 BINDING AGENTS
#2 | 2026-05-07CLEC9A BINDING AGENTS
#3 | 2026-04-23MODULATION OF DENDRITIC CELL LINEAGES
#4 | 2026-03-12CD8 BINDING AGENTS
#5 | 2025-11-27PD-1 AND PD-L1 BINDING AGENTS
#6 | 2025-10-30TARGETED MODIFIED TNF FAMILY MEMBERS
#7 | 2025-02-27CLEC9A BINDING AGENTS AND USE THEREOF
#8 | 2024-11-07SIRP1a TARGETED CHIMERIC PROTEINS AND USES THEREOF
#9 | 2024-10-31CLEC9A BINDING AGENTS AND USE THEREOF
#10 | 2024-05-09FIBROBLAST BINDING AGENTS AND USE THEREOF
#11 | 2024-01-25THERAPEUTIC TARGETING OF NON-CELLULAR STRUCTURES
#12 | 2023-12-14TARGETED THERAPEUTIC AGENTS AND USES THEREOF
#13 | 2023-09-21PD-1 AND PD-L1 BINDING AGENTS
#14 | 2023-09-21IMMUNOSTIMULATORY ADJUVANTS
#15 | 2023-09-14BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF
#16 | 2023-07-27TARGETED MODIFIED IL-1 FAMILY MEMBERS
#17 | 2023-05-11CD8 BINDING AGENTS
#18 | 2023-02-23FUSOKINES INVOLVING CYTOKINES WITH STRONGLY REDUCED RECEPTOR BINDING AFFINITIES
#19 | 2022-11-10CLEC9A BINDING AGENTS
#20 | 2022-10-13Targeted modified TNF family members
#21 | 2022-06-16CD20 BINDING SINGLE DOMAIN ANTIBODIES
#22 | 2022-06-16FMS-LIKE TYROSINE KINASE 3 LIGAND (FLT3L)-BASED CHIMERIC PROTEINS
#23 | 2022-06-09CD8 BINDING AGENTS
#24 | 2022-04-21SIRP1α targeted chimeric proteins and uses thereof
#25 | 2022-04-21MODULATION OF DENDRITIC CELL LINEAGES
#26 | 2022-03-24TARGETED MUTANT INTERFERON-BETA AND USES THEREOF
#27 | 2021-12-30TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF
#28 | 2021-12-16Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
#29 | 2021-08-05Therapeutic targeting of non-cellular structures
#30 | 2021-08-05TARGETING OF HUMAN INTERFERON ANTAGONISTS
#31 | 2021-06-03TARGETED HUMAN-INTERFERON FUSION PROTEINS
#32 | 2021-05-13BISPECIFIC SIGNALING AGENTS AND USES THEREOF
#33 | 2021-01-28Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
#34 | 2021-01-28BI-FUNCTIONAL PROTEINS AND CONSTRUCTION THEREOF
#35 | 2021-01-28Fibroblast binding agents and use thereof
#36 | 2020-12-31PD-1 and PD-L1 binding agents
#37 | 2020-11-12XCR1 BINDING AGENTS AND USES THEREOF
#38 | 2020-09-03Virus-like particle (VLP) based small molecule-protein interaction trap
#39 | 2020-08-20Targeted modified TNF family members
#40 | 2020-08-13TARGETED MODIFIED IL-1 FAMILY MEMBERS
#41 | 2020-07-23CD8 binding agents
#42 | 2020-02-20Targeted mutant interferon-gamma and uses thereof
#43 | 2020-01-30Method for detecting protein-protein interactions in a cell utilizing particle-forming polypeptide-bait fusion proteins and virus-like particles
#44 | 2019-12-05Bispecific signaling agents and uses thereof
#45 | 2019-12-05Targeted modified TNF family members
#46 | 2019-11-21Virus-like particle (VLP) based small molecule-protein interaction trap
#47 | 2019-11-21Clec9A binding agents
#48 | 2019-10-31Membrane span-kinase fusion protein and the uses thereof
#49 | 2019-07-04TARGETED MODIFIED IL-1 FAMILY MEMBERS
#50 | 2019-06-27Targeted mutant interferon-beta and uses thereof
#51 | 2019-06-13Cytoplasmic protein complex comprising a kinase substrate sensor, cells comprising the complex, and associated detection methods
#52 | 2019-05-16Bi-functional chimeric proteins and uses thereof
#53 | 2019-03-28CD20 binding single domain antibodies
#54 | 2019-03-14CD20 BINDING AGENTS AND USES THEREOF
#55 | 2019-03-07CD8 binding agents
#56 | 2019-01-10Fusokines involving cytokines with strongly reduced receptor binding affinities
#57 | 2018-11-22TARGETING OF CYTOKINE ANTAGONISTS
#58 | 2018-11-22Targeting of human interferon antagonists
#59 | 2018-11-22Targeted and mutated human-interferon fusion proteins
#60 | 2018-10-18Targeted modified TNF family members
#61 | 2018-07-05TARGETED MODIFIED IL-1 FAMILY MEMBERS
#62 | 2018-06-21Targeted modified TNF family members
#63 | 2018-06-07Fusokines involving cytokines with strongly reduced receptor binding affinities
#64 | 2018-03-01Targeting of human interferon antagonists
#65 | 2018-02-15Virus-like particle (VLP) based small molecule-protein interaction trap
#66 | 2018-02-01Targeted human-interferon fusion proteins
#67 | 2017-03-16Targeted human-interferon fusion proteins
#68 | 2016-06-09Targeting of human interferon antagonists
#69 | 2016-06-09Targeted modified TNF family members
#70 | 2016-06-02Targeted modified IL-1 family members
#71 | 2015-06-04Trapping mammalian protein-protein complexes in virus-like particles utilizing HIV-1 GAG-bait fusion proteins
#72 | 2015-01-08Membrane span-kinase fusion protein and the uses thereof
#73 | 2014-11-27Targeted human-interferon fusion proteins
#74 | 2014-01-30Cytoplasmic protein complex comprising a kinase substrate sensor cells and associated detection methods
#75 | 2010-12-21Receptor-based interaction trap
#76 | 2010-07-08Reversed mammalian protein-protein interaction trap
#77 | 2010-07-08Receptor-based interaction trap
#78 | 2007-12-20Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
#79 | 2007-11-06Leptin-mediated gene-induction
#80 | 2007-06-26Functional fragment of the leptin receptor
#81 | 2006-03-02Leptin antagonist
631657 ⎘